You are here: Industry Insights > Antifungal

News List

Research Progress on Commonly Used Antifungal Drugs and Their Resistance Mechanisms Against Candida Albicans Infections Xiaomichong
June 28, 2024
Candida albicans is the primary cause of candidiasis, an acute, subacute, or chronic infection that poses a severe threat to human health due to its complex and varying clinical symptoms.
Research Progress on the Antifungal Mechanism of Natural Products Against Candida Species (Part 2) Xiaomichong
June 28, 2024
This article will continue to introduce the antifungal mechanism of natural products achieved through influencing the changes in cellular structures such as the cell wall, cell membrane, and mitochondria of Candida species
Research Progress on the Antifungal Mechanisms of Natural Products Against Candida Species (Part I) Xiaomichong
June 26, 2024
Candida infection is one of the most common opportunistic fungal infections in clinical practice, which often occurs in immunocompromised individuals
‘Cocktail’ of pharmaceuticals identified in Bangladeshi waters europeanpharmaceuticalreview
April 22, 2020
A study of both city and rural water sources identified antimicrobials at every site and suggests the contamination could be causing the emergence of treatment-resistant microbes.
CDC: Superbug Fungus Has Sickened 600 Americans drugs
April 12, 2019
CDC: Superbug Fungus Has Sickened 600 Americans.
Revolution Medicines Raises Another $56 Million and Completes Pivot from Antifungal to Cancer Company biospace
April 25, 2018
Redwood City, California-based Revolution Medicines closed on a Series B financing round worth $56 million.